These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12410747)

  • 1. Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
    Anderson WR; Harris NM; Holmes SA
    BJU Int; 2002 Nov; 90(7):682-5. PubMed ID: 12410747
    [No Abstract]   [Full Text] [Related]  

  • 2. Selections from current literature: androgenetic alopecia: the science behind a new oral treatment.
    Baumann LS; Kelso EB
    Fam Pract; 1998 Oct; 15(5):493-6. PubMed ID: 9848437
    [No Abstract]   [Full Text] [Related]  

  • 3. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
    D'Amico AV; Roehrborn CG
    Lancet Oncol; 2007 Jan; 8(1):21-5. PubMed ID: 17196507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
    Whiting DA
    Eur J Dermatol; 2001; 11(4):332-4. PubMed ID: 11399540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
    Shapiro J; Kaufman KD
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of finasteride on prostate-specific antigen.
    Nadler RB
    Lancet Oncol; 2007 Jan; 8(1):4-5. PubMed ID: 17196505
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
    Whiting DA; Olsen EA; Savin R; Halper L; Rodgers A; Wang L; Hustad C; Palmisano J;
    Eur J Dermatol; 2003; 13(2):150-60. PubMed ID: 12695131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finasteride in the treatment of Japanese men with male pattern hair loss.
    Kawashima M; Hayashi N; Igarashi A; Kitahara H; Maeguchi M; Mizuno A; Murata Y; Nogita T; Toda K; Tsuboi R; Ueki R; Yamada M; Yamazaki M; Matsuda T; Natsumeda Y; Takahashi K; Harada S
    Eur J Dermatol; 2004; 14(4):247-54. PubMed ID: 15319158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finasteride--an update and review.
    Cather JC; Lane D; Heaphy MR; Nelson BR
    Cutis; 1999 Sep; 64(3):167-72. PubMed ID: 10500917
    [No Abstract]   [Full Text] [Related]  

  • 12. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
    Lin JH; Chen WC
    Kaohsiung J Med Sci; 2002 Aug; 18(8):379-85. PubMed ID: 12476680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Androgenetic alopecia: finasteride treated hair loss].
    Heinzl S
    Med Monatsschr Pharm; 1999 Apr; 22(4):124-7. PubMed ID: 10230220
    [No Abstract]   [Full Text] [Related]  

  • 14. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
    Kaufman KD; Olsen EA; Whiting D; Savin R; DeVillez R; Bergfeld W; Price VH; Van Neste D; Roberts JL; Hordinsky M; Shapiro J; Binkowitz B; Gormley GJ
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of prostate cancer with finasteride.
    Burke HB
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806
    [No Abstract]   [Full Text] [Related]  

  • 16. Hair loss in women with hyperandrogenism: four cases responding to finasteride.
    Shum KW; Cullen DR; Messenger AG
    J Am Acad Dermatol; 2002 Nov; 47(5):733-9. PubMed ID: 12399766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer prevention trial yields positive results, but with a few cautions.
    Reynolds T
    J Natl Cancer Inst; 2003 Jul; 95(14):1030-1. PubMed ID: 12865442
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Long-term effects of finasteride on prostate specific antigen levels: results from the Prostate Cancer Prevention Trial.
    Walsh PC
    J Urol; 2006 Jul; 176(1):409-10; author reply 410. PubMed ID: 16753454
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of prostate cancer with finasteride.
    Ross RK; Skinner E; Cote RJ
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562807
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of hormonal therapy for female pattern (androgenic) alopecia.
    Scheinfeld N
    Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.